Invention Grant
US09546166B2 Indolizine derivatives and their use in neurodegenerative diseases
有权
吲哚嗪衍生物及其在神经退行性疾病中的应用
- Patent Title: Indolizine derivatives and their use in neurodegenerative diseases
- Patent Title (中): 吲哚嗪衍生物及其在神经退行性疾病中的应用
-
Application No.: US14814659Application Date: 2015-07-31
-
Publication No.: US09546166B2Publication Date: 2017-01-17
- Inventor: Srinivasa R. Karra , Andreas Goutopoulos
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: EMD Serono Research and Development Institute
- Agent Dwight D. Kim
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D471/04
Abstract:
The present invention relates to indolizine compounds, and pharmaceutically acceptable compositions thereof, useful as antagonists of P2X7, and for the treatment of P2X7-related disorders.
Public/Granted literature
- US20160031879A1 NOVEL INDOLIZINE DERIVATIVES AND THEIR USE IN NEURODEGENERATIVE DISEASES Public/Granted day:2016-02-04
Information query
